Antigen | Reactivity | Application | Clone | InVivoMab Catalog |
InVivoPlus Catalog |
IL-1α | mouse | in vivo IL-1α neutralization | ALF-161 | BE0243 | |
IL-1ß | mouse/rat | in vivo and in vitro IL-1ß neutralization, ELISA | B122 | BE0246 | |
IL-2 | mouse | in vivo and in vitro IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2), ELISPOT, FC | JES6-5H4 | BE0042 | |
IL-2 | mouse | in vivo IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2) | JES6-1A12 | BE0043 | |
IL-2 | mouse | in vivo IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2) | S4B6-1 | BE0043-1 | |
IL-3 | mouse | in vivo and in vitro IL-3 neutralization, in vivo IL-3 receptor stimulation (as a complex with IL-3), ELISA, FC | MP2-8F8 | BE0282 | |
IL-4 | mouse | in vivo and in vitro IL-4 neutralization, in vivo IL-4 receptor stimulation (as a complex with IL-4), FC | 11B11 | BE0045 | BP0045 |
IL-4 | mouse | ELISA, ELISPOT, FC | BVD6-24G2 | BE0199 | |
IL-4 | human | in vitro IL-4 neutralization, FC | MP4-25D2 | BE0240 | |
IL-5 | mouse/human | in vivo IL-5 neutralization, in vivo eosinophil depletion | TRFK5 | BE0198 | |
IL-6 | mouse | in vivo and in vitro IL-6 neutralization | MP5-20F3 | BE0046 | |
IL-7 | mouse/human | in vivo IL-7 neutralization, in vivo IL-7 receptor stimulation (as a complex with IL-7) | M25 | BE0048 | |
IL-9 | mouse | in vivo IL-9 neutralization | 9C1 | BE0181 | |
IL-9 | human | FC, ELISA | MH9A4 | BE0327 | |
IL-10 | mouse | in vivo and in vitro IL-10 neutralization | JES5-2A5 | BE0049 | |
IL-12 | mouse | in vitro IL-12 neutralization | R1-5D9 | BE0052 | |
IL-12 p40 | mouse | in vivo IL-12p40 neutralization, p40 affinity chromatography, IP, ELISA, FC, WB | C17.8 | BE0051 | BP0051 |
IL-12 p70 | human | Functional assays, ELISA, FC | 20C2 | BE0234 | |
IL-12 p75 | mouse | in vivo IL-12p75 neutralization, ELISA | R2-9A5 | BE0233 | |
IL-15 | mouse | in vivo and in vitro IL-15 neutralization | AIO.3 | BE0315 | |
IL-17A | mouse | in vivo IL-17A neutralization | 17F3 | BE0173 | BP0173 |
IL-17F | mouse | in vivo IL-17F neutralization | MM17F8F5.1A9 | BE0303 | |
IL-18 | mouse | in vivo IL-18 neutralization | YIGIF74-1G7 | BE0237 | |
IL-23 (p19) | mouse | in vivo IL-23p19 neutralization; WB | G23-8 | BE0313 | |
IL-27 p28 | mouse | in vivo and in vitro IL-27 p28 neutralization, FC | MM27.7B1 | BE0326 | |
CCL2 (MCP-1) | mouse/human/rat | in vivo CCL2 neutralization, IHC-F | 2H5 | BE0185 | |
CSF1 | mouse | in vitro CSF1 neutralization | 5A1 | BE0204 | |
CXCL9 (MIG) | mouse | IF | MIG-2F5.5 | BE0309 | |
GM-CSF | mouse | in vivo and in vitro GM-CSF neutralization, FC | MP1-22E9 | BE0259 | |
IFNγ | mouse | in vivo and in vitro IFNγ neutralization | R4-6A2 | BE0054 | |
IFNγ | mouse | in vivo and in vitro IFNγ neutralization, ELISPOT, FC | XMG1.2 | BE0055 | BP0055 |
IFNγ | human | in vitro IFNγ neutralization | B133.5 | BE0235 | |
IFNγ | human | FC | B27 | BE0245 | |
IFNγ | mouse | in vivo and in vitro IFNγ neutralization | H22 | BE0312 | |
RANKL (CD254) | mouse | in vivo RANKL blockade | IK22/5 | BE0191 | |
TL1A (TNFSF15) | mouse | in vivo TL1A neutralization, FC | 5G4.2 | BE0323 | |
TNFα | mouse | in vivo and in vitro TNFα neutralization | XT3.11 | BE0058 | BP0058 |
TNFα | mouse/rat/rabbit | in vivo TNFα neutralization, FC | TN3-19.12 | BE0244 |